Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Ship2B
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Combining the power of liquid biopsy and AI-driven epigenetics, we deliver accurate cancer detection. Our approach transforms diagnostics…
Anvil Diagnostics develops MycoScan™, a rapid 3-hour pan-fungal liquid biopsy for invasive fungal infections using proprietary SKIP-Seq™…
SmartCatchFounded 2016
Smartcatch is lifting the current locks on CTC liquid biopsy by developing a range of compact, portable, easy-to-use products that can…
RareCyteVenture round $13.2M · 3 yr ago • Founded 2009 • 201-500 employees
RareCyte, Inc. is a Seattle-based precision biology company developing advanced platforms and services for spatial biology and liquid…
Biomarx logo51-200 employees
Biomarx delivers rapid, low-cost, fully automated liquid biopsy — genomic-grade cancer answers from a blood test in under 2 hours, starting…
Hepta is decoding tissue-level biology from blood, starting with MASH. LiquidTransformer, our liquid biopsy-native AI platform, reads…

Overview

Altum Sequencing delivers ultra-sensitive ctDNA detection for cancer monitoring and MRD assessment. Precision liquid biopsy solutions for oncology, pharma, and clinical research.